Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction

Area of Science:

• Neuroscience
• Regenerative Medicine
• Urology

Background:

• Spinal cord injury (SCI) causes neurogenic lower urinary tract dysfunction (NLUTD), leading to severe complications.
• Current treatments for SCI-induced NLUTD are often unsatisfactory.
• Stem cell therapy offers a potential regenerative approach for SCI and associated NLUTD.

Purpose of the Study:

• To review the current evidence on stem cell therapy for SCI-induced NLUTD.
• To highlight the mechanisms of stem cell action, including differentiation and paracrine effects.
• To identify gaps in knowledge and advocate for further clinical research.

Main Methods:

• Review of preclinical animal studies and human clinical trials on stem cell therapy for SCI.
• Analysis of stem cell types, including mesenchymal stem cells (MSCs) and neural stem cells (NSCs).
• Examination of therapeutic mechanisms, focusing on stem cell differentiation and exosome-mediated effects.

Main Results:

• Animal studies show MSCs and NSCs improve bladder function after SCI.
• Human trials with MSCs demonstrate positive urodynamic changes.
• Data on NSCs and stem cell-derived exosomes for SCI-NLUTD are limited.

Conclusions:

• Stem cell therapy holds significant potential for treating SCI-induced NLUTD.
• Further well-designed clinical trials are essential to determine optimal treatment protocols and efficacy.
• Translating stem cell therapy into a standard treatment requires more robust human data.